Photobiomodulation: How Light Influences Mitochondria, ATP and Cellular Signalling

Light is one of the oldest biological signals encountered by the human body. It does more than enable vision. It contributes to circadian timing, hormonal regulation and the wider sensory environment through which the organism responds to its surroundings.

Photobiomodulation asks a deeper question: what happens when selected wavelengths of red and near-infrared light interact with the cellular environment? Not as heat intended to warm tissue and not as an aggressive performance stimulus, but as an optical input that may, within an appropriate exposure range, become part of cellular signalling.

This is where the real depth of TANVEA Light Systems™ begins. To understand how a physical photon may become biologically relevant, we need to look at mitochondria, cytochrome c oxidase, nitric oxide, ATP, redox signalling, reactive oxygen species, calcium and downstream gene expression.

PHOTOBIOMODULATION IS NOT ENERGY DELIVERED FROM OUTSIDE

The term photobiomodulation describes the concept well: light interacting with biology to modulate a response. It does not mean that light repairs the body instead of the body repairing itself, nor that photons replace cellular biology.

A cell is not a battery. Cellular energetics depend on oxygen, substrates, enzymes, membrane potential, mitochondrial function and redox balance. Light may enter that network as a signal, but it cannot replace the biological foundations required for the cell to respond.

MITOCHONDRIA AS REGULATORY HUBS

Mitochondria are central to ATP production, but their role extends into redox regulation, metabolism, calcium signalling, inflammatory pathways, cellular adaptation and apoptosis.

This is why PBM cannot be understood simply as “more ATP”. Mitochondria continuously respond to the environment of the cell, and that environment influences how an optical signal is interpreted.

CYTOCHROME C OXIDASE: THE BEST-KNOWN PHOTOACCEPTOR MODEL

Cytochrome c oxidase, complex IV of the electron transport chain, has long been investigated as an important photoacceptor in red and near-infrared PBM.

The model is biologically plausible: photon absorption may alter mitochondrial conditions and downstream signalling. However, scientific reviews emphasise that CCO is unlikely to be the only mechanism and that its exact contribution varies by model and wavelength.

TANVEA therefore does not say that light simply “switches mitochondria on”. We use the more accurate language of modulation.

NITRIC OXIDE: A SMALL MOLECULE WITH A LARGE REGULATORY ROLE

Nitric oxide is involved in vascular tone, microcirculation, mitochondrial respiration, neural signalling and inflammatory biology. Some PBM models propose changes in NO binding or availability around CCO, with subsequent effects on respiration and signalling.

But NO is not an enemy. Its role is context dependent and essential to normal physiology. PBM should therefore be understood as interaction with a regulatory network, not as a simple process of removing a mitochondrial inhibitor.

ATP: ENERGY CURRENCY AND SIGNAL

ATP is essential to active cellular processes, but photobiomodulation does not directly manufacture ATP. Under suitable conditions, PBM may influence mitochondrial processes associated with ATP production and utilisation.

ATP can also act extracellularly as a signalling molecule. PBM is therefore as much about cellular communication as it is about cellular energetics.

REDOX SIGNALLING: WHY ROS ARE NOT ONLY HARMFUL

Reactive oxygen species are often associated with oxidative damage, but low and transient ROS levels are also essential signalling tools.

A controlled redox change may influence transcription factors, antioxidant pathways and adaptive responses. This is one reason contemporary PBM research treats mitochondrial activity, ATP, ROS and NO as part of an interconnected regulatory network.

CALCIUM SIGNALLING AND GENE EXPRESSION

Intracellular calcium is one of the fundamental languages of cellular regulation. Changes in Ca²⁺ influence neural signalling, muscular contraction, enzyme activity, mitochondrial function and gene expression.

PBM research explores how optical exposures may influence calcium-related mechanisms through mitochondrial and membrane pathways. This helps explain how a brief physical stimulus may initiate biological processes that continue long after the illumination ends.

BIPHASIC DOSE RESPONSE

Dose is central to photobiomodulation. A stimulus that is too weak may be insufficient; an appropriate exposure may generate a useful response; excessive stimulation does not necessarily provide additional benefit.

This is the biphasic dose response. Experimental PBM studies describe nonlinear patterns in ATP, mitochondrial membrane potential and ROS, which is why more power, a shorter working distance or a longer exposure cannot automatically be assumed to be better.

Biological exposure emerges from spectrum, irradiance, fluence, distance, duration, area, geometry, optics, frequency and target tissue.

OXYGEN AS A LIMIT OF MITOCHONDRIAL RESPONSE

Mitochondrial energetics cannot be separated from oxygen. Oxygen is the terminal electron acceptor in the respiratory chain, so any meaningful discussion of mitochondrial metabolism must also consider ventilation, circulation, haemoglobin, microcirculation and tissue perfusion.

This is why TANVEA naturally connects the logic of Light Systems™ with Oxygen Systems™. Not because more oxygen automatically amplifies PBM, but because mitochondria require oxygen to perform oxidative metabolism.

Light does not replace oxygen.

WHY THE BODY MUST BE READY TO RESPOND

A cell does not exist in isolation. It lives within tissue, and tissue exists within an entire organism. Circulation, hydration, sleep, stress, perfusion and metabolic state all form part of the context in which PBM occurs.

TANVEA therefore does not treat Light Systems™ as an isolated product. Hydro, Thermal, Oxygen and Hydrogen Systems™ represent other layers of the biological environment. This does not make them mandatory prerequisites for PBM or automatic amplifiers. It simply acknowledges that an optical response never occurs outside the body.

Light is the signal.

The body is the receiver.

PHOTOBIOMODULATION AS A SYSTEMS-LEVEL SUBJECT

If PBM is explained only through mitochondria, we still see only part of the picture. If it is explained only through ATP, it quickly becomes an energy-marketing cliché.

Cellular signalling occurs in tissue, tissue belongs to organs, and the organism exists within neural, vascular, endocrine and metabolic environments. Sleep, movement, hydration, stress and oxygen availability are therefore part of the biological context in which a light signal is processed.

This is why TANVEA Light Systems™ are not merely light technologies. Their role is to deliver an appropriately defined optical input into a living system.

WHERE MECHANISM ENDS AND RESPONSIBLE USE BEGINS

Knowing CCO, ATP, NO or ROS is not enough to guarantee intelligent practice. Mechanistic knowledge must be translated into dose, distance, duration, frequency, eye safety, individual sensitivity and medical context.

Photosensitivity, photosensitising medications, certain eye conditions, recent procedures and significant medical conditions call for individual caution. TANVEA Light Systems™ do not replace diagnosis or treatment.

CONCLUSION: FROM PHOTON TO BIOLOGICAL RESPONSE

Photobiomodulation shows that light can be more than illumination. Under appropriate conditions, it may enter processes associated with mitochondria, CCO, nitric oxide, ATP, redox signalling, ROS, calcium and gene expression.

That does not make light a miraculous energy source. Every device does not produce the same exposure, more light does not automatically create more benefit, and cellular recovery does not happen merely because photons reach the body.

PBM becomes meaningful when a physical stimulus meets a biological system capable of responding.

Not as powerful as possible.

But biologically readable.

---

SCIENTIFIC SOURCES

Karu TI. Mitochondrial Signaling in Mammalian Cells Activated by Red and Near-IR Radiation. Photochem Photobiol. 2008.
Karu TI. Is It Time to Consider Photobiomodulation As a Drug Equivalent? Photomed Laser Surg. 2013.
de Freitas LF, Hamblin MR. 2016.
Hamblin MR. 2018.
Huang YY et al. 2011.
Zein R et al. 2018.
Quirk BJ, Whelan HT. 2020.
Dompe C et al. 2020.
Maghfour J et al. 2025.